Eiger BioPharmaceuticals, Inc Earning Date (EIGR)

USA |NASDAQ |USD

EIGR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - - $-0.57
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $2.10M

Eiger Biopharmaceuticals, Inc's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

EIGR Earnings Date & History Chart

EIGR Earnings & Revenue Forecast

EIGR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-2.06 $-2.50 $-1.25

EIGR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.06 $-2.06 $-1.81

EIGR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $34.52M $12.29M $72.20M

EIGR Earnings Date & Revenue History

EIGR Earnings History

|
Show More
Show More

EIGR Revenue History

|
Show More
Show More

Eiger Biopharmaceuticals, Inc Next Earnings Date & Report

EIGR Next Earnings Date & Report Preview: Jun 2022 (FQ)

EIGR's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Eiger Biopharmaceuticals, Inc Previous Earnings Dates & Reports

EIGR Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Eiger Biopharmaceuticals, Inc's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

EIGR Previous Earnings Date & Report Recap: Dec 2021 (FY)

Eiger Biopharmaceuticals, Inc's previous annual earnings date was Mar 10, 2022 for its fiscal year ended Dec 31, 2021.

EIGR's earnings per share (EPS) was $-1.01, beating the consensus analysts forecast of $-1.29 by -21.71% , and higher than the previous year's EPS (Dec 2020) by -56.28%.

Revenues were $12.14M.

The company reported a net income of $-33.92M.

The company ended the fiscal year with $84.60M in total debt, an increase of 166.24% compared to the previous year.